1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-60. [DOI via Crossref] |
|
2. World Health Organization. The Global Status Report on Alcohol and Health 2011. Geneva: WHO, 2011a Available athttp://www.who. int/substance_abuse/publications/global_alcohol_report/en/(last accessed on April 14, 2014). |
|
3. World Health Organization. WHO Statistical Classification of Diseases and Related Health Problems (ICD) 10th revision. Geneva: WHO, 1992a. |
|
4. Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59(1):160-8. [DOI via Crossref] [Pubmed] |
|
5. Room R, Babor T, Rehm J. Alcohol and public health. Lancet. 2005;365(9458):519-30. [DOI via Crossref] |
|
6. Shaw JJ, Shah SA. Rising incidence and demographics of hepatocellular carcinoma in the USA: what does it mean? Expert Rev Gastroenterol Hepatol. 2011;5(3):365-70. [DOI via Crossref] [Pubmed] |
|
7. Martin LM, Sheridan MJ, Younossi ZM. The impact of liver disease on health-related quality of life: a review of the literature. Curr Gastroenterol Rep. 2002;4(1):79-83. [DOI via Crossref] [Pubmed] |
|
8. Lam ET, Lam CL, Lai CL, Yuen MF, Fong DY. Psychometrics of the chronic liver disease questionnaire for Southern Chinese patients with chronic hepatitis B virus infection. World J Gastroenterol. 2009;15(26):3288-3297. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|
9. Donovan D, Mattson ME, Cisler RA, Longabaugh R, Zweben A. Quality of life as an outcome measure in alcoholism treatment research J Stud Alcohol Suppl. 2005;15119-39:92-3. |
|
10. Longabaugh R, Mattson ME, Connors GJ, Cooney NL. Quality of life as an outcome variable in alcoholism treatment research. J Stud Alcohol Suppl. 1994;12:119-29. [DOI via Crossref] [Pubmed] |
|
11. Stein MD, Mulvey KP, Plough A, Samet JH. The functioning and well being of persons who seek treatment for drug and alcohol use. J Subst Abuse. 1998;10(1):75-84. [DOI via Crossref] |
|
12. Dey A, Cederbaum AI. Alcohol and oxidative liver injury Hepatology. 2006;43(2 Suppl 1):S63-74. [DOI via Crossref] [Pubmed] |
|
13. Arteel G, Marsano L, Mendez C, Bentley F, McClain CJ. Advances in alcoholic liver disease. Best Pract Res Clin Gastroenterol. 2003;17: 625-47. [DOI via Crossref] |
|
14. McClain CJ, Hill D, Kugelmas M, Marsano L. Nutrition and liver disease In:(Ed.) Present Knowledge in Nutrition., Washington: International Life Sciences Institute, 2001. pp. 483-96. |
|
15. Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45(2):295-300. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|
16. Becker U, Deis A, Sørensen TI, Grønbaek M, Borch-Johnsen K, Muller CF, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology. 1996; 23(5):1025-9. [DOI via Crossref] [Pubmed] |
|
17. Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, Kawachi I, et al. Alcohol consumption and mortality among women. N Engl J Med. 1995;332(19):1245-50. [DOI via Crossref] [Pubmed] |
|
18. De la Maza MP, Petermann M, Bunout D, Hirsch S. Effects of longterm vitamin E supplementation in alcoholic cirrhotics. J Am Coll Nutr. 1995;14(2):192-6. [DOI via Crossref] [Pubmed] |
|
19. Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of alcoholic liver disease. Clin Mol Hepatol. 2013;19(3):216-54. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|
20. Szuster-Ciesielska A, Daniluk J, Kandefer-Szerszen M. Oxidative stress in the blood of patients with alcohol-related liver cirrhosis. Med Sci Monit. 2002;8(6):CR419-24. [Pubmed] |
|
21. Hill DB, Devalaraja R, Joshi-Barve S, Barve S, McClain CJ. Antioxidants attenuate nuclear factor-kappa B activation and tumor necrosis factoralpha production in alcoholic hepatitis patient monocytes and rat Kupffer cells, in vitro. Clin Biochem. 1999;32(7):563-70. [DOI via Crossref] |
|
22. Evstigneeva RP, Volkov IM, Chudinova VV. (1998) Vitamin E as a universal antioxidant and stabilizer of biological membranes. Membr Cell Biol. 1998;12(2):151-72. [Pubmed] |
|
23. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest. 1995;96(5): 2461-8. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|